B
Bailard Portfolio holdings
AUM
$4.29B
1-Year Return
18.39%
This Quarter Return
+5.67%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$1.59B
AUM Growth
+$296M
(+23%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
33.37%
Holding
455
New
156
Increased
101
Reduced
125
Closed
26
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$54.2M |
| 2 |
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
$39.1M |
| 3 |
Meta Platforms (Facebook)
META
|
$8.49M |
| 4 |
Banco Macro
BMA
|
$7.18M |
| 5 |
Microsoft
MSFT
|
$7.04M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
$59.7M |
| 2 |
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
$30.7M |
| 3 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
$4.24M |
| 4 |
Stryker
SYK
|
$4.02M |
| 5 |
Johnson Controls International
JCI
|
$3.66M |
Sector Composition
| 1 | Technology | 13.33% |
| 2 | Financials | 7.27% |
| 3 | Healthcare | 6.38% |
| 4 | Industrials | 5.43% |
| 5 | Communication Services | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vanguard Large-Cap ETF
VV
$44.6B
| $564K | 0.04% |
4,600
| – | – |
|
302
Norfolk Southern
NSC
$62.3B
| $558K | 0.04% |
3,848
| – | – |
|
303
Blackstone
BX
$133B
| $551K | 0.03% |
17,220
| – | – |
|
304
Mueller Industries
MLI
$10.8B
| $542K | 0.03% |
+30,600
| New | +$542K |
|
305
Neurocrine Biosciences
NBIX
$14.3B
| $535K | 0.03% |
+6,900
| New | +$535K |
|
|
IPCC
306
DELISTED
Infinity Property & Casualty C
IPCC
| $522K | 0.03% |
+4,925
| New | +$522K |
|
307
Labcorp
LH
$23.2B
| $521K | 0.03% |
3,804
-198
| -5% | -$27.1K |
|
308
Sanmina
SANM
$6.44B
| $518K | 0.03% |
+15,700
| New | +$518K |
|
309
Kura Oncology
KURA
$713M
| $517K | 0.03% |
+33,805
| New | +$517K |
|
310
SPDR MSCI ACWI ex-US ETF
CWI
$1.97B
| $513K | 0.03% |
19,725
-450
| -2% | -$11.7K |
|
311
Hurco Companies Inc
HURC
$117M
| $504K | 0.03% |
+11,950
| New | +$504K |
|
312
GE Aerospace
GE
$296B
| $503K | 0.03% |
6,018
-921
| -13% | -$77K |
|
313
Coca-Cola
KO
$292B
| $496K | 0.03% |
10,808
+100
| +0.9% | +$4.59K |
|
314
Mativ Holdings
MATV
$680M
| $494K | 0.03% |
+10,900
| New | +$494K |
|
315
V2X
VVX
$1.79B
| $485K | 0.03% |
+15,707
| New | +$485K |
|
316
QuinStreet
QNST
$920M
| $470K | 0.03% |
+56,121
| New | +$470K |
|
317
Capital One
COF
$142B
| $469K | 0.03% |
4,713
-2,675
| -36% | -$266K |
|
318
Vanguard Russell 2000 Value ETF
VTWV
$833M
| $464K | 0.03% |
4,238
-356
| -8% | -$39K |
|
319
Becton Dickinson
BDX
$55.1B
| $459K | 0.03% |
2,198
+455
| +26% | +$95K |
|
320
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.22B
| $456K | 0.03% |
8,444
-260
| -3% | -$14K |
|
321
Walmart
WMT
$801B
| $456K | 0.03% |
13,845
-2,490
| -15% | -$82K |
|
322
Citigroup
C
$176B
| $453K | 0.03% |
6,083
| – | – |
|
323
iShares Biotechnology ETF
IBB
$5.8B
| $453K | 0.03% |
4,247
-16
| -0.4% | -$1.71K |
|
324
Sempra
SRE
$52.9B
| $446K | 0.03% |
8,344
+750
| +10% | +$40.1K |
|
325
Alnylam Pharmaceuticals
ALNY
$59.2B
| $445K | 0.03% |
+3,500
| New | +$445K |
|